Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: A variant of the reversible cerebral vasoconstriction syndrome?

Cerebrovascular Diseases

Volumn 39, Issue 1, 2015, Pages 31-38

  Wolff, Valérie ^a,b   Armspach, Jean Paul ^b   Lauer, Valérie ^a,b   Rouyer, Olivier ^a,b   Ducros, Anne ^c   Marescaux, Christian ^a   Gény, Bernard ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Cannabis; Intracranial arterial stenosis; Ischaemic stroke; Reversible cerebral vasoconstriction syndrome; Vasoconstriction; Vasoconstriction syndrome; Young people

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; AMPHETAMINE DERIVATIVE; CANNABIS; CLOPIDOGREL; COCAINE; DECONGESTIVE AGENT; HEPARIN; ORAL CONTRACEPTIVE AGENT; TRIPTAN DERIVATIVE; TRYPTAMINE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ARTERY DISSECTION; ARTICLE; BRAIN ARTERY; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CANNABIS USE; CLINICAL FEATURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HEADACHE; HUMAN; ISCHEMIC STROKE WITH REVERSIBLE VASOCONSTRICTION WITHOUT THUNDERCLAP HEADACHE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL CONTRACEPTIVE USE; POSTERIOR CEREBRAL ARTERY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; SCREENING; SUBARACHNOID HEMORRHAGE; SUPERIOR CEREBELLAR ARTERY; THUNDERCLAP HEADACHE; YOUNG ADULT; ADVERSE EFFECTS; BRAIN VASOSPASM; CANNABIS SMOKING; COHORT ANALYSIS; COMPLICATION; CONSTRICTION, PATHOLOGIC; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; STROKE; VASOCONSTRICTION;

ADULT; BRAIN ISCHEMIA; CEREBRAL ARTERIES; COHORT STUDIES; CONSTRICTION, PATHOLOGIC; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA SMOKING; NASAL DECONGESTANTS; PROSPECTIVE STUDIES; STROKE; TRYPTAMINES; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 84922278955     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000369776     Document Type: Article

References (30)

1. Yamamoto FI: Ischemic stroke in young adults: an overview of etiological aspects. Arq Neuropsiquiatr 2012; 70: 462-466.
2. Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, Raul JS, Sabourdy C, Boujan F, Jahn C, Beaujeux R, Marescaux C: Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 2011; 42: 1778-1780.
3. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB: Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146: 34-44.
4. Sattar A, Manousakis G, Jensen MB: Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther 2010; 8: 1417-1421.
5. Chen SP, Fuh JL, Wang SJ: Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother 2011; 11: 1265-1276.
6. Singhal AB, Hajj-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH: Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011; 68: 1005-1012.
7. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG: The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130: 3091-3101.
8. Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG: Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 2010; 41: 2505-2511.
9. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ: Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002; 58: 130-133.
10. Chen SP, Fuh JL, Wang SJ, Chang FC, Lirng JF, Fang YC, Shia BC, Wu JC: Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol 2010; 67: 648-656.
11. Noda K, Fukae J, Fujishima K, Mori K, Urabe T, Hattori N, Okuma Y: Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage, reversible posterior leukoencephalopathy, and cerebral infarction. Intern Med 2011; 50: 1227-1233.
12. Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, Wang SJ: Transcranial color doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol 2008; 63: 751-757.
13. Mawet J, Boukobza M, Franc J, Sarov M, Arnold M, Bousser MG, Ducros A: Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology 2013; 81: 821-824.
14. Robert T, Kawkabani Marchini A, Oumarou G, Uské A: Reversible cerebral vasoconstriction syndrome identification of prognostic factors. Clin Neurol Neurosurg 2013;115: 2351-2357.
15. Ducros A: Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012; 11: 906-917.
16. Ji R, Schwamm LH, Pervez MA, Singhal AB: Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013; 70: 51-57.
17. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Tatlisumak T: Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009; 40: 1195-1203.
18. Wolff V, Armspach JP, Beaujeux R, Manisor M, Rouyer O, Lauer V, et al: High frequency of intracranial arterial stenoses and cannabis use in ischaemic stroke in the young. Cerebrovasc Dis 2014; 37: 438-443.
19. Von Sarnowski B, Schminke U, Tatlisumak T, Putaala J, Grittner U, Kaps M, Tobin WO, Kinsella JA, McCabe DJ, Hennerici MG, Fazekas F, Norrving B, Kessler C, Rolfs A; sifap1 investigators: Prevalence of stenosis and occlusions of brain-supplying arteries in young stroke patients. Neurology 2013; 80: 1287-1294.
20. Katz BS, Fugate JE, Ameriso SF, Pujol-Lereis VA, Mandrekar J, Flemming KD, Kallmes DF, Rabinstein AA: Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol 2014; 71: 68-73.
21. Cheng YC, Kuo KH, Lai TH: A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome. J Headache Pain 2014; 15: 13.
22. O'Sullivan SE, Kendall DA, Randall MD: Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. Eur J Pharmacol 2005; 507: 211-221.
23. Kunos G, Jarai Z, Varga K, Liu J, Wang L, Wagner JA: Cardiovascular effects of endocannabinoids-the plot thickens. Prostaglandins Other Lipid Mediat 2000; 61: 71-84.
24. Barbosa PP, Lapa AJ, Lima-Landman MT, Valle JR: Vasoconstriction induced by delta 9-tetrahydrocannabinol on the perfused rabbit ear artery. Arch Int Pharmacodyn Ther 1981; 252: 253-261.
25. Adams MD, Earnhardt JT, Dewey WL, Harris LS: Vasoconstrictor actions of delta 8-and delta 9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther 1976; 196: 649-656.
26. Wolff V, Armspach JP, Lauer V, Rouyer O, Bataillard M, Marescaux C, Geny B: Cannabis-related stroke: myth or reality? Stroke 2013; 44: 558-563.
27. Thomas G, Kloner RA, Rezkalla S: Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014; 113: 187-190.
28. Jouanjus E, Lapeyre-Mestre M, Micallef J; French Association of the Regional Abuse and Dependence Monitoring Centres (CEIPA) Working Group on Cannabis Complications: Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc 2014; 3:e000638.
29. Desbois AC, Cacoub P: Cannabis-associated arterial disease. Ann Vasc Surg 2013; 27: 996-1005.
30. Chen SP, Fuh JL, Wang SJ, Tsai SJ, Hong CJ, Yang AC: Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes. PLoS One 2011; 6:e18024.